Health care markets, and specifically ophthalmology biotech and medtech markets, have largely erased early 2020 losses that were due to the COVID-19 pandemic, according to a speaker at Octane’s virtual Ophthalmology Technology Summit.
“The markets bounced about 40% to 50% off their lows to erase most of the losses. They’re really back from this year. It’s important to note health care stocks have been a shining light throughout the pandemic. Biotech in particular has been really rewarded during this environment,” Mike Giaquinto, senior managing director of SVB
Uncategorized